Literature DB >> 9494771

Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women.

D J Hunter1, J E Manson, G A Colditz, L Chasan-Taber, L Troy, M J Stampfer, F E Speizer, W C Willett.   

Abstract

Histories of oral contraceptive (OC) use were reported by 116,686 women aged 25 to 42 years in the Nurses' Health Study II on a self-administered questionnaire accompanied by a color photo booklet of all OC preparations ever marketed in the US. To evaluate the quality of this information, we compared the responses of a randomly selected sample of 215 participants with their data from a subsequent, detailed telephone interview using a structured life events calendar. Agreement for a history of ever having used OC was high between the two methods (exact agreement 99%). Reported durations of use were equivalent (mean duration 42.7 months by telephone interview and 44.6 months by questionnaire). The Spearman correlation for duration of use calculated from the two methods was 0.94 (p < 0.0001). For a subset of women for whom we were able to obtain OC prescription records, the medical record confirmed the use of an identical or equivalent brand in 75% of intervals of reported use. Acceptably valid OC histories were obtained with a self-administered questionnaire.

Entities:  

Keywords:  Americas; Cohort Analysis; Contraception; Contraceptive Methods; Contraceptive Usage; Data Analysis; Data Collection; Data Quality; Data Reporting; Developed Countries; Error Sources; Family Planning; Measurement; North America; Northern America; Oral Contraceptives; Research Methodology; Research Report; United States; Validity

Mesh:

Substances:

Year:  1997        PMID: 9494771     DOI: 10.1016/s0010-7824(97)00172-8

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  42 in total

1.  Factors modifying the association between hormone-replacement therapy and breast cancer risk.

Authors:  Beate Pesch; Yon Ko; Hiltrud Brauch; Ute Hamann; Volker Harth; Sylvia Rabstein; Christiane Pierl; Hans-Peter Fischer; Christian Baisch; Christina Justenhoven; Ulrich Ranft; Thomas Brüning
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease.

Authors:  Kelly Claire Simon; Honglei Chen; Xiang Gao; Michael A Schwarzschild; Alberto Ascherio
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

3.  Oral contraceptives, reproductive factors and risk of inflammatory bowel disease.

Authors:  Hamed Khalili; Leslie M Higuchi; Ashwin N Ananthakrishnan; James M Richter; Diane Feskanich; Charles S Fuchs; Andrew T Chan
Journal:  Gut       Date:  2012-05-22       Impact factor: 23.059

4.  Measures of obesity and risk of Crohn's disease and ulcerative colitis.

Authors:  Hamed Khalili; Ashwin N Ananthakrishnan; Gauree G Konijeti; Leslie M Higuchi; Charles S Fuchs; James M Richter; Andrew T Chan
Journal:  Inflamm Bowel Dis       Date:  2015-02       Impact factor: 5.325

5.  Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Joanne Kotsopoulos; Jan Lubinski; Jacek Gronwald; Cezary Cybulski; Rochelle Demsky; Susan L Neuhausen; Charmaine Kim-Sing; Nadine Tung; Susan Friedman; Leigha Senter; Jeffrey Weitzel; Beth Karlan; Pal Moller; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2014-12-18       Impact factor: 7.396

6.  Oral contraceptive use and incident urinary incontinence in premenopausal women.

Authors:  Mary K Townsend; Gary C Curhan; Neil M Resnick; Francine Grodstein
Journal:  J Urol       Date:  2009-03-17       Impact factor: 7.450

7.  Comparison of prospective daily diaries and retrospective recall to measure oral contraceptive adherence.

Authors:  Larissa R Brunner Huber; Elizabeth C Broel; Ashley N Mitchelides; Jacek Dmochowski; Michael Dulin; Delia Scholes
Journal:  Contraception       Date:  2013-03-15       Impact factor: 3.375

8.  Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health Study.

Authors:  Kristin E Burke; Ashwin N Ananthakrishnan; Paul Lochhead; Po-Hong Liu; Ola Olen; Jonas F Ludvigsson; James M Richter; Shelley S Tworoger; Andrew T Chan; Hamed Khalili
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

9.  Early life factors and risk of inflammatory bowel disease in adulthood.

Authors:  Hamed Khalili; Ashwin N Ananthakrishnan; Leslie M Higuchi; James M Richter; Charles S Fuchs; Andrew T Chan
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

10.  Hormone therapy increases risk of ulcerative colitis but not Crohn's disease.

Authors:  Hamed Khalili; Leslie M Higuchi; Ashwin N Ananthakrishnan; JoAnn E Manson; Diane Feskanich; James M Richter; Charles S Fuchs; Andrew T Chan
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.